Relating to breast implants, the Food and Drug Administration, and public health.
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Sep 19, 1996)
Expresses the sense of the House of Representatives that the Food and Drug Administration should: (1) ensure that women with breast cancer and other women seeking breast reconstruction have enhanced access to silicone gel breast implants; (2) eliminate requirements that those women participate in clinical studies in order to obtain the implants; and (3) issue a definitive statement on the relationship (or lack thereof) between silicone gel breast implants and connective tissue disease, classic auto-immune symptoms, and other serious diseases.
What just happenedSep 25, 1996
Referred to the Subcommittee on Health and Environment.
Who’s behind it
- Introduced in HouseSep 19, 1996
- Sep 25, 1996CommitteeH11000
Referred to the Subcommittee on Health and Environment.
Health and Environment Subcommittee - Sep 19, 1996IntroReferralH11100
Referred to the House Committee on Commerce.
Energy and Commerce Committee - Sep 19, 1996IntroReferralIntro-H
Introduced in House
- Sep 19, 1996IntroReferral1000
Introduced in House